Personal information

Other IDs

Loop profile: 1210789

Activities

Collapse all

Employment (1)

Hospital Sant Joan de Déu: Barcelona, Catalunya, ES

2000-09-15 to present | MD, PhD (Hematology and Oncology)
Employment
Source: Self-asserted source
Susana Rives

Education and qualifications (2)

Universitat de Barcelona: Barcelona, Catalunya, ES

2011-09-01 to 2013-12-13 | PhD (Hematology)
Education
Source: Self-asserted source
Susana Rives

Universitat de Barcelona: Barcelona, Catalunya, ES

1988-09-15 to 1994-06-30 | MD (Medicine )
Education
Source: Self-asserted source
Susana Rives

Works (50 of 97)

Items per page:
Page 1 of 2

RNA‐sequencing: A reliable tool to unveil transcriptional landscape of paediatric B‐other acute lymphoblastic leukaemia

British Journal of Haematology
2025-03-30 | Journal article
DOI: 10.1111/bjh.20056
Contributors: Clara Vicente‐Garcés; Guerau Fernández; Elena Esperanza‐Cebollada; Mercè Richarte‐Franqués; Alba Crespo‐Carrasco; Sara Montesdeoca; Ignacio Isola; Edurne Sarrate; Esther Cuatrecasas; Susana Rives et al.
Source: check_circle
Crossref

A miRNA signature related to stemness identifies high‐risk patients in paediatric acute myeloid leukaemia

British Journal of Haematology
2023-07 | Journal article
DOI: 10.1111/bjh.18746
Contributors: Elena Esperanza‐Cebollada; Soledad Gómez‐González; Sara Perez‐Jaume; Nerea Vega‐García; Clara Vicente‐Garcés; Mercè Richarte‐Franqués; Susana Rives; Albert Català; Montserrat Torrebadell; Mireia Camós
Source: check_circle
Crossref

Central nervous system therapy in acute lymphoblastic leukemia: no more, no less

Haematologica
2023-06-15 | Journal article
DOI: 10.3324/haematol.2023.283275
Part of ISSN: 1592-8721
Part of ISSN: 0390-6078
Contributors: Susana Rives
Source: Self-asserted source
Susana Rives

Data from Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

2023-04-04 | Preprint
DOI: 10.1158/2643-3230.c.6550538
Contributors: Michael A. Pulsipher; Xia Han; Shannon L. Maude; Theodore W. Laetsch; Muna Qayed; Susana Rives; Michael W. Boyer; Hidefumi Hiramatsu; Gregory A. Yanik; Tim Driscoll et al.
Source: check_circle
Crossref

Data from Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

2023-04-04 | Preprint
DOI: 10.1158/2643-3230.c.6550538.v1
Contributors: Michael A. Pulsipher; Xia Han; Shannon L. Maude; Theodore W. Laetsch; Muna Qayed; Susana Rives; Michael W. Boyer; Hidefumi Hiramatsu; Gregory A. Yanik; Tim Driscoll et al.
Source: check_circle
Crossref

Supplementary Data from Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

2023-04-04 | Preprint
DOI: 10.1158/2643-3230.22544129
Contributors: Michael A. Pulsipher; Xia Han; Shannon L. Maude; Theodore W. Laetsch; Muna Qayed; Susana Rives; Michael W. Boyer; Hidefumi Hiramatsu; Gregory A. Yanik; Tim Driscoll et al.
Source: check_circle
Crossref

Supplementary Data from Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

2023-04-04 | Preprint
DOI: 10.1158/2643-3230.22544129.v1
Contributors: Michael A. Pulsipher; Xia Han; Shannon L. Maude; Theodore W. Laetsch; Muna Qayed; Susana Rives; Michael W. Boyer; Hidefumi Hiramatsu; Gregory A. Yanik; Tim Driscoll et al.
Source: check_circle
Crossref

Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)

Frontiers in Pediatrics
2023-03-20 | Journal article
DOI: 10.3389/fped.2023.1140637
Part of ISSN: 2296-2360
Contributors: Celia Moreno; Eduardo Ramos-Elbal; Pablo Velasco; Yurena Aguilar; Berta Gonzáález Martínez; Carolina Fuentes; Águeda Molinos; Pilar Guerra-García; Pilar Palomo; Jaime Verdu et al.
Source: Self-asserted source
Susana Rives

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

Journal of Clinical Oncology
2023-03-20 | Journal article
DOI: 10.1200/JCO.22.00642
Contributors: Theodore W. Laetsch; Shannon L. Maude; Susana Rives; Hidefumi Hiramatsu; Henrique Bittencourt; Peter Bader; André Baruchel; Michael Boyer; Barbara De Moerloose; Muna Qayed et al.
Source: check_circle
Crossref

Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study

The Lancet Haematology
2022-10 | Journal article
DOI: 10.1016/s2352-3026(22)00225-3
Part of ISSN: 2352-3026
Contributors: Susana Rives
Source: Self-asserted source
Susana Rives

Results of ARI‐0001 CART19 cell therapy in patients with relapsed/refractory CD19‐positive acute lymphoblastic leukemia with isolated extramedullary disease

American Journal of Hematology
2022-06 | Journal article
DOI: 10.1002/ajh.26519
Part of ISSN: 0361-8609
Part of ISSN: 1096-8652
Source: Self-asserted source
Susana Rives
grade
Preferred source (of 2)‎

Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial

Leukemia
2022-04-25 | Journal article
DOI: 10.1038/s41375-022-01576-3
Part of ISSN: 0887-6924
Part of ISSN: 1476-5551
Source: Self-asserted source
Susana Rives

CD34+CD19-CD22+ B-cell progenitors might underlie phenotypic escape in patients treated with CD19-directed therapies

Blood
2022-04-14 | Journal article
DOI: 10.1182/blood.2021014840
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Susana Rives

Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia

Leukemia
2022-04-14 | Journal article
DOI: 10.1038/s41375-022-01550-z
Part of ISSN: 0887-6924
Part of ISSN: 1476-5551
Source: Self-asserted source
Susana Rives

Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia

Frontiers in Molecular Biosciences
2022-04-07 | Journal article
DOI: 10.3389/fmolb.2022.854098
Part of ISSN: 2296-889X
Source: Self-asserted source
Susana Rives

Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL‐SEHOP‐PETHEMA‐2013

Journal of Thrombosis and Haemostasis
2022-03-27 | Journal article
DOI: 10.1111/jth.15699
Part of ISSN: 1538-7933
Part of ISSN: 1538-7836
Source: Self-asserted source
Susana Rives

Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?

Frontiers in Pediatrics
2022-01-25 | Journal article
DOI: 10.3389/fped.2021.784024
Part of ISSN: 2296-2360
Source: Self-asserted source
Susana Rives

Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia

Hematological Oncology
2022-01-02 | Journal article
DOI: 10.1002/hon.2960
Part of ISSN: 0278-0232
Part of ISSN: 1099-1069
Source: Self-asserted source
Susana Rives

Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

Blood Cancer Discovery
2022-01-01 | Journal article
DOI: 10.1158/2643-3230.BCD-21-0095
Contributors: Michael A. Pulsipher; Xia Han; Shannon L. Maude; Theodore W. Laetsch; Muna Qayed; Susana Rives; Michael W. Boyer; Hidefumi Hiramatsu; Gregory A. Yanik; Tim Driscoll et al.
Source: check_circle
Crossref

Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy

Journal for ImmunoTherapy of Cancer
2021-12 | Journal article
DOI: 10.1136/jitc-2021-003644
Part of ISSN: 2051-1426
Source: Self-asserted source
Susana Rives

CAR T cells in CNS-relapsed leukaemia: one step forward

The Lancet Haematology
2021-10 | Journal article
DOI: 10.1016/s2352-3026(21)00281-7
Part of ISSN: 2352-3026
Source: Self-asserted source
Susana Rives

Outcomes for paediatric acute leukaemia patients admitted to the paediatric intensive care unit

European Journal of Pediatrics
2021-10-25 | Journal article
DOI: 10.1007/s00431-021-04292-9
Part of ISSN: 0340-6199
Part of ISSN: 1432-1076
Source: Self-asserted source
Susana Rives

Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia

Journal for ImmunoTherapy of Cancer
2021-08 | Journal article
DOI: 10.1136/jitc-2020-002287
Contributors: John E Levine; Stephan A Grupp; Michael A Pulsipher; Andrew C Dietz; Susana Rives; G Douglas Myers; Keith J August; Michael R Verneris; Jochen Buechner; Theodore W Laetsch et al.
Source: check_circle
Crossref

Lower incidence of clinical allergy with PEG‐asparaginase upfront versus the sequential use of native E. coli asparaginase followed by PEG‐ASP in pediatric patients with acute lymphoblastic leukemia

Hematological Oncology
2021-08-16 | Journal article
DOI: 10.1002/hon.2914
Part of ISSN: 0278-0232
Part of ISSN: 1099-1069
Source: Self-asserted source
Susana Rives

Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.

Blood advances
2021-07 | Journal article
DOI: 10.1182/bloodadvances.2020004144
PMID: 34297046
Contributors: Niemeyer CM; Flotho C; Lipka DB; Starý J; Rössig C; Baruchel A; Klingebiel T; Micalizzi C; Michel G; Nysom K et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Remission, treatment failure, and relapse in pediatric ALL: An international consensus of the Ponte-di-Legno Consortium.

Blood
2021-06 | Journal article
DOI: 10.1182/blood.2021012328
PMID: 34192312
Contributors: Buchmann S; Schrappe M; Baruchel A; Biondi A; Borowitz MJ; Campbell M; Cario G; Cazzaniga G; Escherich G; Harrison CJ et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2021-06 | Journal article
DOI: 10.1007/s12094-021-02649-y
PMID: 34076861
Contributors: Rubio-San-Simón A; Hladun Alvaro R; Juan Ribelles A; Castañeda Heredia A; Guerra-García P; Verdú-Amorós J; Andrés M; Cañete A; Rives S; Moreno L
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Blinatumomab to improve the outcome of children with relapsed B-cell acute lymphoblastic leukemia.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2021-03 | Journal article
DOI: 10.1007/s12094-021-02590-0
PMID: 33742341
Contributors: Fuster JL; Bautista F; González B; Fernández JM; Rives S; Dapena JL; Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP)
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Kinetics of humoral deficiency in CART19-treated children and young adults with acute lymphoblastic leukaemia

Bone Marrow Transplantation
2021-02-14 | Journal article
DOI: 10.1038/s41409-020-01027-6
Contributors: A. Deyà-Martínez; A. Alonso-Saladrigues; A. P. García; A. Faura; M. Torrebadell; A. Vlagea; A. Català; A. Esteve-Solé; M. Juan; S. Rives et al.
Source: check_circle
Crossref

Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy

Blood Advances
2021-01-26 | Journal article
DOI: 10.1182/bloodadvances.2020002757
Contributors: Jochen Buechner; Stephan A. Grupp; Hidefumi Hiramatsu; David T. Teachey; Susana Rives; Theodore W. Laetsch; Gregory A. Yanik; Patricia Wood; Rakesh Awasthi; Lan Yi et al.
Source: check_circle
Crossref

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

Journal of Personalized Medicine
2020-11-26 | Journal article
DOI: 10.3390/jpm10040244
Part of ISSN: 2075-4426
Source: Self-asserted source
Susana Rives
grade
Preferred source (of 2)‎

CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19<sup>+</sup> Relapsed/Refractory Malignancies.

Molecular therapy : the journal of the American Society of Gene Therapy
2020-09 | Journal article
DOI: 10.1016/j.ymthe.2020.09.027
PMID: 33010231
Contributors: Ortíz-Maldonado V; Rives S; Castellà M; Alonso-Saladrigues A; Benítez-Ribas D; Caballero-Baños M; Baumann T; Cid J; Garcia-Rey E; Llanos C et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic.

Pediatric blood & cancer
2020-07 | Journal article
DOI: 10.1002/pbc.28557
PMID: 32672895
PMC: PMC7404582
Contributors: Faura A; Rives S; Lassaletta Á; Sebastián E; Madero L; Huerta J; García-Morín M; Martínez AP; Sisinni L; Astigarraga I et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

[CAR-T immunotherapy in pediatric hemato-oncology… present and future].

Anales de pediatria
2020-06 | Journal article
DOI: 10.1016/j.anpedi.2020.04.023
PMID: 32527709
PMC: PMC7279730
Contributors: Juan M; Rives S
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP).

British journal of haematology
2020-04 | Journal article
DOI: 10.1111/bjh.16647
PMID: 32314348
Contributors: Fuster JL; Molinos-Quintana A; Fuentes C; Fernández JM; Velasco P; Pascual T; Rives S; Dapena JL; Sisinni L; López-Godino O et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment.

European journal of cancer (Oxford, England : 1990)
2020-04 | Journal article
DOI: 10.1016/j.ejca.2020.03.021
PMID: 32305831
PMC: PMC7141482
Contributors: Hrusak O; Kalina T; Wolf J; Balduzzi A; Provenzi M; Rizzari C; Rives S; Del Pozo Carlavilla M; Alonso MEV; Domínguez-Pinilla N et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial.

Frontiers in immunology
2020-03 | Journal article
DOI: 10.3389/fimmu.2020.00482
PMID: 32528460
PMC: PMC7259426
Contributors: Castella M; Caballero-Baños M; Ortiz-Maldonado V; González-Navarro EA; Suñé G; Antoñana-Vidósola A; Boronat A; Marzal B; Millán L; Martín-Antonio B et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

[Immunotherapy with CAR-T cells in paediatric haematology-oncology].

Anales de pediatria
2020-02-24 | Journal article
DOI: 10.1016/j.anpedi.2019.12.014
PMID: 32107177
Source: Self-asserted source
Susana Rives
grade
Preferred source (of 2)‎

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.

Frontiers in pediatrics
2020-01 | Journal article
DOI: 10.3389/fped.2020.614521
PMID: 33614543
PMC: PMC7892614
Contributors: Vega-García N; Perez-Jaume S; Esperanza-Cebollada E; Vicente-Garcés C; Torrebadell M; Jiménez-Velasco A; Ortega M; Llop M; Abad L; Vagace JM et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain

Clinical and Translational Oncology
2019-12 | Journal article
DOI: 10.1007/s12094-019-02221-9
Part of ISSN: 1699-048X
Part of ISSN: 1699-3055
Source: Self-asserted source
Susana Rives

Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial.

The Lancet. Oncology
2019-10 | Journal article
DOI: 10.1016/s1470-2045(19)30493-0
PMID: 31606419
PMC: PMC7480957
Contributors: Laetsch TW; Myers GD; Baruchel A; Dietz AC; Pulsipher MA; Bittencourt H; Buechner J; De Moerloose B; Davis KL; Nemecek E et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions.

Molecular therapy. Methods & clinical development
2018-12 | Journal article
DOI: 10.1016/j.omtm.2018.11.010
PMID: 30623002
PMC: PMC6319086
Contributors: Castella M; Boronat A; Martín-Ibáñez R; Rodríguez V; Suñé G; Caballero M; Marzal B; Pérez-Amill L; Martín-Antonio B; Castaño J et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases.

British journal of haematology
2018-07 | Journal article
DOI: 10.1111/bjh.15436
PMID: 29978456
Contributors: Vega-García N; Malatesta R; Estella C; Pérez-Jaume S; Esperanza-Cebollada E; Torrebadell M; Català A; Gassiot S; Berrueco R; Ruiz-Llobet A et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Impact of polymorphisms in apoptosis-related genes on the outcome of childhood acute lymphoblastic leukaemia.

British journal of haematology
2018-05 | Journal article
DOI: 10.1111/bjh.15415
PMID: 29808934
Contributors: Cabezas M; Camós M; Rives S; Garcia-Orad A; Lopez-Lopez E; Dapena JL; Caballín MR; Armengol G
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

The New England journal of medicine
2018-02 | Journal article
DOI: 10.1056/nejmoa1709866
PMID: 29385370
PMC: PMC5996391
Contributors: Maude SL; Laetsch TW; Buechner J; Rives S; Boyer M; Bittencourt H; Bader P; Verneris MR; Stefanski HE; Myers GD et al.
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Blood culture time to positivity in oncology pediatric patients.

Enfermedades infecciosas y microbiologia clinica (English ed.)
2017-10-27 | Journal article
DOI: 10.1016/j.eimc.2017.09.008
PMID: 29107395
Source: Self-asserted source
Susana Rives

Intravenous pentamidine for Pneumocystis pneumonia prophylaxis in children undergoing autologous hematopoietic stem cell transplant.

Pediatric blood & cancer
2017-05 | Journal article
DOI: 10.1002/pbc.26558
PMID: 28466513
Contributors: Montoya Tamayo C; Bossacoma Busquets F; Vinent Genestar J; Fortuny Guasch C; Santa-Maria López V; Rives S
Source: Self-asserted source
Susana Rives via Europe PubMed Central

Spuriously low pulse oximetry saturation associated with hemoglobin Sydney in a child and relatives: Identification of this unstable hemoglobin may avoid unnecessary testing and hospital admissions

Pediatric Blood & Cancer
2017-05 | Journal article
DOI: 10.1002/pbc.26317
Part of ISSN: 1545-5009
Source: Self-asserted source
Susana Rives

[Early clinical trials in paediatric oncology in Spain: a nationwide perspective].

Anales de pediatria (Barcelona, Spain : 2003)
2017-03-06 | Journal article
DOI: 10.1016/j.anpedi.2016.07.007
PMID: 28279690
Source: Self-asserted source
Susana Rives

Asparaginase use for the treatment of acute lymphoblastic leukemia.

Medicina clinica
2017-01 | Journal article
DOI: 10.1016/j.medcli.2016.12.006
PMID: 28118965
Contributors: Barba P; Dapena JL; Montesinos P; Rives S
Source: Self-asserted source
Susana Rives via Europe PubMed Central
Items per page:
Page 1 of 2

Peer review (2 reviews for 2 publications/grants)

Review activity for The lancet. (1)
Review activity for Transplantation and cellular therapy. (1)
How many people are using ORCID?